Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Qualigen Therapeutics, Inc. (RTTR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/22/2022 |
4
| Poirier Michael S. (Chairman and CEO) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Bought 30,000 shares
@ $0.57, valued at
$17.1k
|
|
| 06/15/2022 |
4
| BROIDRICK AMY S. (President/CSO) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Bought 30,000 shares
@ $0.62, valued at
$18.6k
|
|
| 12/10/2021 |
4
| BROIDRICK AMY S. (President/ChiefStrategyOfficer) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $1.24, valued at
$372k
|
|
| 12/10/2021 |
4
| ARSHAD TARIQ (SVP/Chief Medical Officer) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $1.24, valued at
$372k
|
|
| 08/20/2021 |
4
| Kruger Kurt H (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Bought 4,000 shares
@ $1.23, valued at
$4.9k
Bought 4,000 shares
@ $1.22, valued at
$4.9k
|
|
| 05/18/2021 |
4
| ARSHAD TARIQ (SVP/Chief Medical Officer) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.8, valued at
$180k
|
|
| 05/17/2021 |
3
| ARSHAD TARIQ (SVP/Chief Medical Officer) has filed a Form 3 on Qualigen Therapeutics, Inc. |
| 04/26/2021 |
4
| BROIDRICK AMY S. (EVP, Chief Strategy Officer) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Bought 4,500 shares
@ $2.03, valued at
$9.1k
|
|
| 04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2020 |
4
| Kruger Kurt H (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Bought 4,000 shares
@ $2.935, valued at
$11.7k
|
|
| 12/29/2020 |
4
| BROIDRICK AMY S. (Executive VP, CSO) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $3.52, valued at
$528k
|
|
| 12/08/2020 |
4
| EMERY SIDNEY W JR (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $3.52, valued at
$176k
|
|
| 12/07/2020 |
3
| EMERY SIDNEY W JR (Director) has filed a Form 3 on Qualigen Therapeutics, Inc. |
| 11/23/2020 |
4
| Kruger Kurt H (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Bought 1,400 shares
@ $3.549, valued at
$5k
Bought 4,600 shares
@ $3.462, valued at
$15.9k
|
|
| 08/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/28/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| Ritter Ira E. (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $5.13, valued at
$256.5k
|
|
| 06/08/2020 |
4
| David Richard A. (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $5.13, valued at
$256.5k
|
|
| 06/08/2020 |
4
| Poirier Michael S. (Chairman, President & CEO) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $5.13, valued at
$5.1M
|
|
| 06/08/2020 |
4
| Abdul-Ahad Wajdi (Vice President, R & D, CSO) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 500,000 options to buy
@ $5.13, valued at
$2.6M
|
|
| 06/08/2020 |
4
| Kruger Kurt H (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $5.13, valued at
$256.5k
|
|
| 06/08/2020 |
4
| Sinha Shishir K. (Vice President of Operations) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 500,000 options to buy
@ $5.13, valued at
$2.6M
|
|
| 06/08/2020 |
4
| Korenberg Matthew E (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $5.13, valued at
$256.5k
|
|
| 06/08/2020 |
4
| Lotz Christopher L. (Vice President of Finance, CFO) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Granted 600,000 options to buy
@ $5.13, valued at
$3.1M
|
|
| 05/27/2020 |
3
| SEKISUI DIAGNOSTICS, LLC (10% Owner) has filed a Form 3 on Qualigen Therapeutics, Inc. |
| 05/27/2020 |
4
| Abdul-Ahad Wajdi (VP, R&D, CSO) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Acquired 7,971 options to buy
@ $2.0663, valued at
$16.5k
Acquired 8,857 options to buy
@ $2.5405, valued at
$22.5k
|
|
| 05/27/2020 |
4
| Sinha Shishir K. (Vice President of Operations) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Acquired 8,857 options to buy
@ $2.0663, valued at
$18.3k
Acquired 26,570 options to buy
@ $2.0663, valued at
$54.9k
|
|
| 05/27/2020 |
4
| Poirier Michael S. (Chairman, President & CEO.) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Acquired 169,192 shares
@ $0
Acquired 22,142 options to buy
@ $2.0663, valued at
$45.8k
Acquired 29,847 options to buy
@ $2.0663, valued at
$61.7k
Acquired 22,142 options to buy
@ $2.5405, valued at
$56.3k
Acquired 14,437 options to buy
@ $2.5405, valued at
$36.7k
|
|
| 05/27/2020 |
4
| Lotz Christopher L. (VP of Finance, CFO.) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Acquired 9,841 shares
@ $0
Acquired 22,142 options to buy
@ $2.0663, valued at
$45.8k
Acquired 29,847 options to buy
@ $2.0663, valued at
$61.7k
Acquired 22,142 options to buy
@ $2.5405, valued at
$56.3k
Acquired 3,543 options to buy
@ $2.5405, valued at
$9k
|
|
| 05/27/2020 |
4
| Kruger Kurt H (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Acquired 8,857 options to buy
@ $2.5405, valued at
$22.5k
|
|
| 05/27/2020 |
4
| David Richard A. (Director) has filed a Form 4 on Qualigen Therapeutics, Inc.|
Txns:
| Acquired 8,857 options to buy
@ $2.5405, valued at
$22.5k
|
|
| 05/27/2020 |
3
| Poirier Michael S. (Chairman, President and CEO) has filed a Form 3 on Qualigen Therapeutics, Inc. |
|
|
|